Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 1, 2000, Pages 73-77

  Hutchison, Michael L ^a   Bonell, Emma C ^a   Poxton, Ian R ^a   Govan, John R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cystic fibrosis; Endotoxicity; Inflammation; Respiratory pathogen

Indexed keywords

CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA;

ALCALIGENES; ARTICLE; BLOOD; BORDETELLA; BURKHOLDERIA CEPACIA; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; RALSTONIA SOLANACEARUM; STENOTROPHOMONAS MALTOPHILIA; WAUTERSIA EUTROPHA;

CELL LINE; CYSTIC FIBROSIS; CYTOKINES; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES; RESPIRATORY TRACT INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033989426     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00165-0     Document Type: Article

References (13)

1. Riordan J.R., Rommens J.M., Kerem B.S., Alon N., Rozmahel R., Grzelczak K., Zielenski J., Lok J., Plasic S., Chou J.L., Drumm M.L., Ianuzzi M.C., Collins F.S., Tsui L.C. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 245:1989;1066-1073.
2. + permeability in cystic fibrosis human primary cell cultures. J. Physiol. 405:1988;77-103.
3. Govan J.R.W., Deretic V. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:1996;539-549.
4. Denton M., Todd N.J., Littlewood J.M. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;402-405.
5. Denton M. Stenotrophomonas maltophilia: An emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:1997;15-19.
6. Hutchison M.L., Govan J.R.W. Pathogenicity of microbes associated with cystic fibrosis. Microb. Infect. 1:1999;1005-1014.
7. Peltroche-Llacsahuanga H., Hasse G. Persistent airway colonisation with Alcaligenes xylosoxidans in two brothers with cystic fibrosis. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;132-134.
8. Johnson K.G., Perry M. Improved techniques for the preparation of bacterial lipopolysaccharides. Can. J. Microbiol. 22:1976;29-34.
9. Evans E., Poxton I.R., Govan J.R.W. Lipopolysaccharide chemotypes of Burkholderia cepacia. J. Med. Microbiol. 48:1999;825-832.
10. Shaw D., Poxton I.R., Govan J.R.W. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:1995;99-106.
11. Palfreyman R.W., Watson M.L., Eden C., Smith A.W. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect. Immun. 65:1997;617-622.
12. Zughaier S.M., Ryley H.C., Jackson S.K. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun. 67:1999;1505-1507.
13. Hughes J.E., Stewart J., Barclay G.R., Govan J.R.W. Priming of neutrophil respiratory burst activity by lipopolysaccharides from Burkholderia cepacia. Infect. Immun. 65:1997;4281-4287.